X Linked Reticulate Pigmentary Disorder C1845050
A rare genetic disorder causing skin pigmentation changes and recurrent infections. Primarily affects males. Treatment focuses on managing symptoms and preventing infections.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dermatologic Surveillance
Regular skin examinations monitor pigmentation changes, assess for secondary skin infections, and screen for potential skin malignancies that may occur in affected areas.
Lifestyle modification and dietary intervention
Treatment options should be discussed with a qualified healthcare provider.
Sun Protection Measures
Strict sun avoidance and broad-spectrum sunscreen application protect affected skin from UV damage. Protective clothing and seeking shade reduce pigmentation worsening.
Additional treatment options
Topical Treatment for Skin Symptoms
Prescription topical treatments may address secondary infections, inflammation, or discomfort in affected skin areas. Treatment is individualized based on symptoms.
medicationCosmetic Camouflage Techniques
Professional camouflage makeup and self-tanning products can help conceal pigmentation differences and improve cosmetic appearance and self-esteem.
complementaryPsychological Counseling for Visible Differences
Support addresses social anxiety, self-esteem concerns, and coping strategies for living with a visible skin condition. Group therapy connects patients with shared experiences.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is X Linked Reticulate Pigmentary Disorder C1845050?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Levinsohn JL, Boggon E, Burk RD, et al. X-linked reticulate pigmentary disorder: A systematic review. Am J Med Genet A. 2019.
Starokadomskyy P, Glukhov A, Qin Q, et al. Immunologic characterization and treatment outcomes in XLPI patients. J Invest Dermatol. 2021.
International Society of Pediatric Dermatology. Consensus guidelines for diagnosis and management of reticulate pigmentary disorders. Pediatr Dermatol. 2022.
Gao M, Wang H, Chen Q, et al. Novel pathogenic variant in POLA1 identified in familial XLPI with recurrent infections. Hum Mutat. 2020.
Medication Comparisons
Compare medications used to treat X Linked Reticulate Pigmentary Disorder C1845050. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy